GE HealthCare GEHC recently unveiled its next-generation SIGNA MRI portfolio, the 3T SIGNA Bolt and 1.5T SIGNA Sprint with Freelium, aimed at boosting efficiency, advancing precision diagnostics and improving sustainability. Powered by the new SIGNA One AI workflow platform, the systems are designed to help radiology departments manage rising imaging demand and reduce workflow bottlenecks.
The launch strengthens GEHC’s competitive position by combining high-performance imaging with smarter, more accessible MRI technology. With SIGNA Bolt targeting advanced clinical and research needs and SIGNA Sprint offering a helium-light, ventless design to expand installation flexibility, management expects the new lineup to support greater productivity, lower operating costs and wider adoption of AI-enabled MRI solutions globally.
Following the announcement, the company’s shares traded flat at Friday’s closing. In the year-to-date period, shares have gained 2.3% compared with the industry’s 4.9% growth. The S&P 500 has gained 18.3% in the same time frame.
Once FDA clearance is secured, these next-generation SIGNA systems should meaningfully strengthen GEHC’s long-term growth by driving higher adoption of AI-enabled, energy-efficient MRI platforms across both inpatient and outpatient settings. The combination of faster workflows, lower operating costs, helium-light design and advanced imaging performance positions GEHC to win market share, expand recurring software-driven revenue through SIGNA One, and deepen customer stickiness as providers increasingly shift toward scalable, sustainable MRI solutions.
GEHC currently has a market capitalization of $36.44 billion.
Zacks Investment Research
Image Source: Zacks Investment Research
GE HealthCare’s new 3T SIGNA Bolt is positioned as its most advanced high-field MRI system yet, aiming to blend ultra-high gradient performance with intelligent RF architecture to elevate both routine clinical work and complex research imaging. The system is designed to deliver strong diagnostic quality through outstanding gradient power, deep-learning–based applications and AI-enabled workflow acceleration via SIGNA One.
GEHC is also targeting sustainability and efficiency, highlighting that SIGNA Bolt can support fast exams, lower operational costs and seamless movement between clinical and research use cases. With dedicated neurology and oncology pathway tools and developer kits to simplify research, the platform is built to help institutions translate advanced capabilities into everyday patient care.
On the 1.5T side, SIGNA Sprint with Freelium takes a different strategic angle by focusing on accessibility, sustainability and operational autonomy. The system uses less than 1 percent of the helium required in conventional MRI designs, thanks to GEHC’s sealed, ventless Freelium magnet. This opens up installation flexibility, allowing providers to place MRI capabilities in more locations, including remote regions with limited infrastructure. Despite its sustainable design, the system still aims for high clinical performance, offering exceptional homogeneity, a high signal-to-noise ratio and sharp image clarity. Deep-learning reconstruction tools like AIR Recon DL and Sonic DL further enhance consistency across anatomies. Features like Scanning Autonomy through the SIGNA One interface and automated magnet recovery via Autoramp are designed to reduce reliance on highly experienced technologists and minimize downtime.
The backbone connecting both systems is SIGNA One, GEHC’s next-generation AI workflow platform built to reduce inefficiencies across the full MRI exam cycle. SIGNA One brings an intuitive interface that can shorten training time, a redesigned patient table for better comfort and transport, and an automated camera system that handles landmark detection, patient positioning verification and real-time visual guidance.
The SIGNA One also introduces contactless respiratory and peripheral gating, removing the need for external sensors and streamlining setup. High-resolution in-room consoles give technologists better control without interrupting workflow. GEHC is integrating NVIDIA GPUs to accelerate deep-learning reconstruction and elevate performance, positioning SIGNA One as a key driver of productivity and consistency for both experienced and less-experienced users.
Currently, GEHC carries a Zacks Rank #3 (Hold).
Some better-ranked stocks from the broader medical space are Medpace Holdings MEDP, Intuitive Surgical ISRG and Boston Scientific BSX.
Medpace, currently carrying a Zacks Rank #2 (Buy), reported a third-quarter 2025 earnings per share (EPS) of $3.86, which surpassed the Zacks Consensus Estimate by 10.29%. Revenues of $659.9 million beat the Zacks Consensus Estimate by 3.04%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
MEDP has an estimated earnings growth rate of 17.1% for 2025 compared with the industry’s 16.6% growth. The company beat earnings estimates in each of the trailing four quarters, the average surprise being 14.28%.
Intuitive Surgical, sporting a Zacks Rank #1 at present, posted a third-quarter 2025 adjusted EPS of $2.40, exceeding the Zacks Consensus Estimate by 20.6%. Revenues of $2.51 billion topped the Zacks Consensus Estimate by 3.9%.
ISRG has an estimated long-term earnings growth rate of 15.7% compared with the industry’s 11.9% growth. The company’s earnings outpaced estimates in each of the trailing four quarters, the average surprise being 16.34%.
Boston Scientific, currently carrying a Zacks Rank #2, reported a third-quarter 2025 adjusted EPS of 75 cents, which surpassed the Zacks Consensus Estimate by 5.6%. Revenues of $5.07 billion outperformed the Zacks Consensus Estimate by 1.9%.
BSX has an estimated long-term earnings growth rate of 16.4% compared with the industry’s 13.5% growth. The company’s earnings beat estimates in each of the trailing four quarters, the average surprise being 7.36%.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Boston Scientific Corporation (BSX) : Free Stock Analysis Report
Intuitive Surgical, Inc. (ISRG) : Free Stock Analysis Report
Medpace Holdings, Inc. (MEDP) : Free Stock Analysis Report
GE HealthCare Technologies Inc. (GEHC) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
